Dir
Richard L. Lindstrom, MD is a board-certified ophthalmologist and renowned leader in corneal, cataract, refractive, and laser surgery, serving as a Director on the Board of Ocular Therapeutix, Inc. (OCUL) since 2012.[[1]](https://www.ocutx.com/board-member/richard-lindstrom-md/)[[2]](https://fintool.com/app/research/companies/OCUL/people/richard-lindstrom) He is the founder and attending surgeon at Minnesota Eye Consultants, P.A. since 1989, CEO and Chairman of Lindstrom Restoration, and holds over 45 patents for ophthalmic innovations including intraocular lenses, solutions, and instruments used globally.[[1]](https://www.ocutx.com/board-member/richard-lindstrom-md/)[[2]](https://fintool.com/app/research/companies/OCUL/people/richard-lindstrom)[[5]](https://sydnexis.com/leadership/richard-lindstrom-m-d-2/) Recently, as a Class II director, he acquired 10,000 shares of OCUL stock on May 8, 2025, at $6.96 per share.[[8]](https://www.tradingview.com/news/tradingview:e51d02582587a:0-ocular-therapeutix-director-richard-l-lindstrom-acquires-10-000-shares/)
Dr. Lindstrom earned a B.A. in pre-medical studies, B.S. in Medicine, and M.D. from the University of Minnesota, with fellowships in cornea, anterior segment, and glaucoma.[[1]](https://www.ocutx.com/board-member/richard-lindstrom-md/)[[2]](https://fintool.com/app/research/companies/OCUL/people/richard-lindstrom) His career highlights include past presidency of the American Society of Cataract and Refractive Surgery (2007-2008) and International Society of Refractive Surgery (1993-1994), adjunct clinical professor emeritus at the University of Minnesota Department of Ophthalmology, and board roles at companies like LENSAR, Inc., Harrow, and Surface Ophthalmics.[[1]](https://www.ocutx.com/board-member/richard-lindstrom-md/)[[2]](https://fintool.com/app/research/companies/OCUL/people/richard-lindstrom)[[3]](https://surfaceophthalmics.com/member/richard-lindstrom/)[[4]](https://crstoday.com/articles/may-2023/richard-l-lindstrom-md)
View full insider profile →
